Abu Dhabi: The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, has signed a Memorandum of Understanding (MoU) with Sanofi, a research and development-driven, AI-powered healthcare biopharma company, at the BIO International Convention 2025 in Boston, USA. The collaboration aims to leverage the Emirate's health-tech ecosystem and advanced research infrastructure to drive the development of new global vaccines and strengthen regional capabilities in vaccine manufacturing.
According to Emirates News Agency, the agreement was signed in the presence of Dr. Noura Khamis Al Ghaithi, Under-Secretary of the Department of Health - Abu Dhabi, and Laurie Gery, Global Head of Business Development, Vaccines at Sanofi. The signatories included Dr. Asma Al Mannaei, Executive Director of the Health Life Sciences Sector at the DoH, and Baptiste de Clarens, General Manager Greater Gulf, Vaccines at Sanofi.
Dr. Asma Al Mannaei stated that the partnership with Sanofi is designed to expedite the development of new global vaccines, aiming to shorten the timeline from early research to public availability. By utilising advanced technologies, real-time data analysis, and conducting parallel clinical trial phases, the collaboration seeks to set new benchmarks for resilience, innovation, and international partnerships. Abu Dhabi's globally connected environment for leading research will drive transformative change to safeguard community health and contribute to global health security.
Both entities will work on streamlining regulatory processes, enhancing manufacturing preparedness, and promoting knowledge sharing between local and international experts. This partnership aligns with Abu Dhabi's strategic goal to become a leading centre for bio- and pharmaceutical innovation, highlighting the emirate's commitment to advancing proactive, technology-driven healthcare solutions.
Baptiste de Clarens emphasized that the MoU with the Department of Health - Abu Dhabi represents an important step towards advancing global health security. It reflects a shared interest in addressing global health challenges through scientific partnership and explores opportunities for public-private collaboration in healthcare innovation.
Furthermore, the Department and Sanofi will focus on advancing clinical research and development planning, optimising resource allocation, and establishing foundational terms for funding and access. These efforts aim to enhance healthcare resilience and sustainability across Abu Dhabi's healthcare sector and beyond, expanding access to quality care for patients both locally and globally.